INSIGHT 2: a phase II study of tepotinib plus osimertinib in MET-amplified NSCLC
Вставка
- Опубліковано 27 вер 2024
- In the latest Publication Perspective by The Video Journal of Biomedicine, Egbert Smith discusses a recent article published in Future Oncology, titled 'INSIGHT 2: a phase II study of tepotinib plus osimertinib in MET-amplified NSCLC and first-line osimertinib resistance'.
Subscribe: www.youtube.co....
Visit The Video Journal of Biomedicine: www.biomedicin...
Follow us on Twitter: / vjofbiomedicine
LinkedIn: / vide. .
Facebook: / videojournal. .
Watch here: www.futuremedi...
#INSIGHT2 #NSCLC #LungCancer